Compare WVE & MBIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WVE | MBIN |
|---|---|---|
| Founded | 2012 | 1990 |
| Country | Singapore | United States |
| Employees | N/A | 735 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.3B |
| IPO Year | 2015 | N/A |
| Metric | WVE | MBIN |
|---|---|---|
| Price | $7.25 | $49.54 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 3 |
| Target Price | $29.50 | ★ $43.67 |
| AVG Volume (30 Days) | ★ 6.4M | 152.8K |
| Earning Date | 04-28-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 0.81% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,704,000.00 | N/A |
| Revenue This Year | N/A | $31.76 |
| Revenue Next Year | $85.67 | $3.73 |
| P/E Ratio | ★ N/A | $12.29 |
| Revenue Growth | ★ 149.43 | N/A |
| 52 Week Low | $5.02 | $27.25 |
| 52 Week High | $21.73 | $50.26 |
| Indicator | WVE | MBIN |
|---|---|---|
| Relative Strength Index (RSI) | 34.60 | 73.03 |
| Support Level | $6.93 | $40.82 |
| Resistance Level | $7.67 | N/A |
| Average True Range (ATR) | 0.33 | 1.23 |
| MACD | 0.23 | 0.27 |
| Stochastic Oscillator | 47.80 | 88.62 |
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Merchants Bancorp is a United States-based bank holding company operating multiple lines of business focused on FHA multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. Its segments include Multi-family Mortgage Banking, which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing, which offers mortgage warehouse financing, commercial loans and deposit services; and the Banking segment, which generates maximum revenue and provides portfolio lending for multi-family and healthcare facility loans, residential mortgage banking, agricultural lending, SBA lending and community banking.